Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]
- PMID: 9833912
- DOI: 10.1016/s0168-8278(98)80255-9
Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]
Abstract
Background/aims: Intrahepatic cholestasis of pregnancy is characterised by increased levels of serum bile acids. Ursodeoxycholic acid therapy corrects the serum bile acid profile. The aims of this study were: (i) to investigate bile acid excretion into colostrum of women with intrahepatic cholestasis of pregnancy; (ii) to compare concentrations of bile acids in serum and colostrum of non-treated and ursodeoxycholic acid-treated patients; and (iii) to clarify whether ursodeoxycholic acid is eliminated into colostrum following treatment.
Methods: Bile acids were assessed by gas chromatography and high-performance liquid chromatography in serum collected at delivery, and in colostrum obtained at 2+/-1 days after labour, from patients with intrahepatic cholestasis of pregnancy, non-treated (n=9) and treated (n=7) with ursodeoxycholic acid (14 mg/kg bw per day, for 14+/-7 days) until parturition.
Results: The concentration of total bile acids in colostrum from patients with intrahepatic cholestasis of pregnancy was higher than in normals (23.3+/-14.8 micromol/l vs. 0.7+/-0.2 micromol/l, p<0.01) and cholic acid was a major species (19.0+/-13.1 micromol/l), reflecting the elevated concentrations in maternal serum (48.9+/-21.0 micromol/l, total bile acids; 33.9+/-16.7 micromol/l, cholic acid. Following ursodeoxycholic acid administration, total bile acids and cholic acid levels in colostrum diminished to 5.7+/-2.5 micromol/l and 3.6+/-1.5 micromol/l, respectively; the proportion of cholic acid decreased (60.6+/-8.0% vs. 76.8+/-5.0%, p<0.05). The ursodeoxycholic acid concentration in colostrum was maintained following treatment; its increased percentage (9.4+/-3.2% vs. 1.0+/-0.2%, p<0.01) was still lower than in maternal serum (20.8+/-3.6%, p<0.05). Only a small proportion (<1%) of lithocholic acid was found in colostrum following therapy.
Conclusions: Bile acid concentrations are elevated and cholic acid is the major species accumulating in colostrum, reflecting serum bile acid profiles in intrahepatic cholestasis of pregnancy. Ursodeoxycholic acid therapy decreases endogenous bile acid levels in colostrum.
Comment in
-
Cholestasis of pregnancy: ursodeoxycholic acid therapy.J Hepatol. 1998 Nov;29(5):827-8. doi: 10.1016/s0168-8278(98)80266-3. J Hepatol. 1998. PMID: 9833923 No abstract available.
Similar articles
-
Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.BJOG. 2019 Dec;126(13):1633-1640. doi: 10.1111/1471-0528.15926. Epub 2019 Sep 26. BJOG. 2019. PMID: 31483939 Free PMC article.
-
New Insights on Intrahepatic Cholestasis of Pregnancy.Clin Liver Dis. 2016 Feb;20(1):177-89. doi: 10.1016/j.cld.2015.08.010. Epub 2015 Oct 9. Clin Liver Dis. 2016. PMID: 26593298 Review.
-
Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.Ann Hepatol. 2002 Jan-Mar;1(1):20-8. Ann Hepatol. 2002. PMID: 15114292 Review.
-
Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.Gut. 1999 Sep;45(3):446-52. doi: 10.1136/gut.45.3.446. Gut. 1999. PMID: 10446117 Free PMC article.
-
Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.J Hepatol. 1998 Jan;28(1):91-8. doi: 10.1016/s0168-8278(98)80207-9. J Hepatol. 1998. PMID: 9537870 Clinical Trial.
Cited by
-
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).J Clin Transl Hepatol. 2023 Jun 28;11(3):736-746. doi: 10.14218/JCTH.2022.00347. Epub 2023 Feb 10. J Clin Transl Hepatol. 2023. PMID: 36969891 Free PMC article.
-
Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk.Sci Rep. 2022 Nov 15;12(1):19543. doi: 10.1038/s41598-022-24253-y. Sci Rep. 2022. PMID: 36379995 Free PMC article.
-
Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70-/- mice with human-like bile acids.Pediatr Res. 2023 May;93(6):1582-1590. doi: 10.1038/s41390-022-02303-5. Epub 2022 Sep 23. Pediatr Res. 2023. PMID: 36151295 Free PMC article.
-
Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.Cochrane Database Syst Rev. 2019 Jul 5;7(7):CD012546. doi: 10.1002/14651858.CD012546.pub2. Cochrane Database Syst Rev. 2019. PMID: 31283001 Free PMC article.
-
Lactation during cholestasis: Role of ABC proteins in bile acid traffic across the mammary gland.Sci Rep. 2017 Aug 7;7(1):7475. doi: 10.1038/s41598-017-06315-8. Sci Rep. 2017. PMID: 28785115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical